Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Efavirenz/emtricitabine/tenofovir disoproxil
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Atripla 600mg/200mg/245mg tablets
0503010ANBBAAAA
|
Atripla | Efavirenz/emtricitabine/tenofovir disoproxil | Infections | 5 |
|
Efavirenz 600mg / Emtr 200mg /Tenofovir disoproxil 245mg tab
0503010ANAAAAAA
|
Efavirenz/emtricitabine/tenofovir disoproxil | Efavirenz/emtricitabine/tenofovir disoproxil | Infections | 3 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.